Silvia Santa-Dalla

Via Gattamelata 64
Padova, 35128, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine.

On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 21, 2024

Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling.

Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling.

Journal: Frontiers in oncology

Published: June 08, 2022

PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation".

PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation".

Journal: Frontiers in oncology

Published: May 11, 2021

Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines.

Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines.

Journal: Cellular & molecular immunology

Published: September 03, 2020

Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.

Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.

Journal: Oncogene

Published: March 10, 2020

Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1.

Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1.

Journal: Oncoimmunology

Published: January 30, 2017

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.

Journal: Frontiers in immunology

Published: November 29, 2016

Reverse immunoediting: When immunity is edited by antigen.

Reverse immunoediting: When immunity is edited by antigen.

Journal: Immunology letters

Published: March 04, 2016

Functional avidity-driven activation-induced cell death shapes CTL immunodominance.

Functional avidity-driven activation-induced cell death shapes CTL immunodominance.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: September 24, 2014

Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma.

Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma.

Journal: Immunology

Published: September 09, 2014

Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications.

Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications.

Journal: British journal of cancer

Published: August 23, 2012

Survivin expression impacts prognostically on NSCLC but not SCLC.

Survivin expression impacts prognostically on NSCLC but not SCLC.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 15, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026